In humans, in vitro studies have shown that KIR+ CD8+ T cells can specifically eliminate gliadin-specific pathogenic CD4+ T cells in celiac disease through class I MHC–dependent cytotoxicity (46). This evidence concerns the gene KIR3DL1 and celiac disease.